Vaso Corporation Reports First Quarter 2026 Financial Results
On May 15, 2026, Vaso Corporation announced its financial results for the first quarter of 2026, reporting a total revenue of $19.4 million, a slight decrease of 0.5% from the previous year; however, revenue increased by 4.8% when excluding the divested healthcare IT service business. Gross profit rose by 1.9% year-over-year to $11.6 million. The company also reported a net loss of $887,000, an improvement from the $1.1 million loss during the same period in 2025. SG&A expenses increased by 2.6%, resulting in an operating loss of $1.3 million. Vaso remains cautiously optimistic about the year ahead, considering the seasonal nature of its profitability.
PLAINVIEW, N.Y., May 15, 2026 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months ended March 31, 2026.